644
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Sex-based influence on clinical outcomes after drug-eluting stent implantation in real-world patients: insight from the FOCUS registry

, , , , &
Pages 185-195 | Received 19 Jul 2016, Accepted 07 Sep 2016, Published online: 04 Nov 2016

References

  • Malenka DJ, O'Connor GT, Quinton H, Wennberg D, Robb JF, Shubrooks S, et al. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. A regional prospective study of 13,061 procedures. Northern New England Cardiovascular Disease Study Group. Circulation. 1996;94:99–104.
  • Cowley MJ, Mullin SM, Kelsey SF, Kent KM, Gruentzig AR, Detre KM, et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. Circulation. 1985;71:90–7.
  • Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM. Results of percutaneous transluminal coronary angioplasty in women. 1985–1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation. 1993;87:720–7.
  • Jacobs AK, Johnston JM, Haviland A, Brooks MM, Kelsey SF, Holmes DJ, et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry. J Am Coll Cardiol. 2002;39:1608–14.
  • Mehilli J, Kastrati A, Bollwein H, Dibra A, Schuhlen H, Dirschinger J, et al. Gender and restenosis after coronary artery stenting. Eur Heart J. 2003;24:1523–30.
  • Grines CL, Schreiber T. Sex differences in the drug-eluting stent era: do they still exist? JACC Cardiovasc Interv. 2012;5:311–12.
  • Lansky AJ, Costa RA, Mooney M, Midei MG, Lui HK, Strickland W, et al. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol. 2005;45:1180–5.
  • Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, et al. Gender-specific outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2007;50:2111–16.
  • Zhang F, Ge J, Qian J, Ge L, Zhou J. Real-world use of the second-generation cobalt-chromium sirolimus-eluting stents: 12-month results from the prospective multicentre FOCUS registry. EuroIntervention. 2012;8:896–903.
  • Zhang F, Yang J, Qian J, Ge L, Zhou J, Ge J. Long-term performance of the second-generation cobalt-chromium sirolimus-eluting stents in real-world clinical practice: 3-year clinical outcomes from the prospective multicenter FOCUS registry. J Thorac Dis. 2016;8:1609–18.
  • Lempereur M, Magne J, Cornelis K, Hanet C, Taeymans Y, Vrolix M, et al. Impact of gender difference in hospital outcomes following percutaneous coronary intervention. Results of the Belgian Working Group on Interventional Cardiology (BWGIC) registry. EuroIntervention. 2016;12:e216–23.
  • Bell MR, Holmes DJ, Berger PB, Garratt KN, Bailey KR, Gersh BJ. The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty. JAMA. 1993;269:2091–5.
  • Weintraub WS, Wenger NK, Kosinski AS, Douglas JJ, Liberman HA, Morris DC, et al. Percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol. 1994;24:81–90.
  • Berger JS, Brown DL. Gender-age interaction in early mortality following primary angioplasty for acute myocardial infarction. Am J Cardiol. 2006;98:1140–3.
  • Mehilli J, Kastrati A, Dirschinger J, Bollwein H, Neumann FJ, Schomig A. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA. 2000;284:1799–805.
  • Mehilli J, Kastrati A, Dirschinger J, Pache J, Seyfarth M, Blasini R, et al. Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA. 2002;287:210–15.
  • Malenka DJ, Wennberg DE, Quinton HA, O'Rourke DJ, McGrath PD, Shubrooks SJ, et al. Gender-related changes in the practice and outcomes of percutaneous coronary interventions in Northern New England from 1994 to 1999. J Am Coll Cardiol. 2002;40:2092–101.
  • Yamaji K, Shiomi H, Morimoto T, Toyota T, Ono K, Furukawa Y, et al. Influence of sex on long-term outcomes after implantation of bare-metal stent: a multicenter report from the Coronary Revascularization Demonstrating Outcome Study-Kyoto (CREDO-Kyoto) Registry Cohort-1. Circulation. 2015;132:2323–33.
  • Katz G, Harchandani B, Shah B. Drug-eluting stents: the past, present, and future. Curr Atheroscler Rep. 2015;17:485. doi: 10.1007/s11883-014-0485-2.
  • Byrne RA, Joner M, Kastrati A. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. Eur Heart J. 2015;36:3320–31.
  • Onuma Y, Kukreja N, Daemen J, Garcia-Garcia HM, Gonzalo N, Cheng JM, et al. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv. 2009;2:603–10.
  • Mikhail GW, Gerber RT, Cox DA, Ellis SG, Lasala JM, Ormiston JA, et al. Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the “TAXUS Woman” analysis. JACC Cardiovasc Interv. 2010;3:1250–9.
  • Stefanini GG, Kalesan B, Pilgrim T, Raber L, Onuma Y, Silber S, et al. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv. 2012;5:301–10.
  • Sato H, Kasai T, Miyauchi K, Kubota N, Kajimoto K, Miyazaki T, et al. Long-term outcomes of women with coronary artery disease following complete coronary revascularization. J Cardiol. 2011;58:158–64.
  • Funakoshi S, Furukawa Y, Ehara N, Morimoto T, Kaji S, Yamamuro A, et al. Clinical characteristics and outcomes of Japanese women undergoing coronary revascularization therapy. Circ J. 2011;75:1358–67.
  • Toyota T, Furukawa Y, Ehara N, Funakoshi S, Morimoto T, Kaji S, et al. Sex-based differences in clinical practice and outcomes for Japanese patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J. 2013;77:1508–17.
  • Brown RA, Williams M, Barker CM, Mauri L, Meredith IT, Fajadet J, et al. Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results. Catheter Cardiovasc Interv. 2010;76:804–13.
  • Regueiro A, Fernandez-Rodriguez D, Brugaletta S, Martin-Yuste V, Masotti M, Freixa X, et al. Sex-related Impact on clinical outcome of everolimus-eluting versus bare-metal stents in ST-segment myocardial infarction. Insights From the EXAMINATION Trial. Rev Esp Cardiol (Engl Ed). 2015;68:382–9.
  • Ferrante G, Presbitero P, Corrada E, Campo G, Bolognese L, Vassanelli C, et al. Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial. Am Heart J. 2012;163:104–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.